24th Annual Hypertension, Diabetes & Dyslipidemia Conference
COVID-19 / Coronavirus Update:
This conference will NOT be cancelled. If you are unable to travel due to COVID-19 travel restrictions, you can still earn live CME credit via live streaming webcast.
24th Annual Hypertension, Diabetes & Dyslipidemia Conference is organized by Continuing Education Company, Inc. (CEC). The symposium is held from Jun 26 - 28, 2020 at Charleston Gaillard Center, Charleston, South Carolina, United States of America.
This activity is intended for physicians specializing in Internal Medicine, Family or General Practice, Geriatric Medicine, Endocrinology, Lipidology and Hypertension Specialists. Healthcare professionals including physician assistants and nurse practitioners specializing in these areas or those managing patients with Hypertension, Diabetes, and/or Hyperlipidemia, alone or in combination, may benefit from this activity.
AAFP: This Live activity, 24th Annual Hypertension, Diabetes, and Dyslipidemia Conference, with a beginning date of June 26, 2020 has been reviewed and is acceptable for up to 15.00 Prescribed credit(s) by the American Academy of Family Physicians.
AMA PRA Category 1 Credits ™: Continuing Education Company assigns this live activity for a maximum of 15 AMA PRA Category 1 Credits™.
Earn a total of 30 credits with our Special CME Offer! Attend the 24th Annual Hypertension, Diabetes & Dyslipidemia Conference (15 CME Credits) and you will earn a FREE online 15 credit CME course from CME365™.
*Offer valid only for participants who attend all days of the live 24th Annual Medical Conference on Hypertension, Diabetes, & Dyslipidemia. Access to the online CME course will be sent to registrants after they have attended and successfully completed the live conference. The online CME course is not transferable. This offer is not valid if you cancel your registration or are a no show at the live conference. Webcast participants are not eligible for this offer.
ABIM MOC: On Successful completion of this CME activity, a participant will be able to apply for the evaluation component, allowing them to earn up to 15 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program.
This three-day intensive conference, held on June 26-28, 2020 in Charleston, South Carolina, discusses all the issues confronting clinicians who treat challenging patients with diabetes, hypertension, and dyslipidemia and how to apply this knowledge to everyday practice.
Over the past several years controversies in the appropriate level of Hemoglobin A1C, BP, and LDL-Cholesterol for outcome growth continue to occur in Type 2 Diabetes, Hypertension, and Dyslipidemia, respectively. Despite the results from the ACCORD, VADT, and ADVANCE studies suggesting the benefits on reducing macrovascular disease with a more intensive strategy for A1C reduction remains unclear, individualized A1C targets for those with newly diagnosed diabetes compared to those with long-standing disease are often recommended. In addition, controversy continues to exist in cholesterol control as recent guidelines suggest that one should decide on the intensity of statin-based therapy for outcome improvement in those at risk for or with established ASCVD rather than a specific goal of LDL-cholesterol reduction. Finally, the recent SPRINT trial has suggested that lower targets for BP reduction than ever achieved before can and should be achieved in high-risk adults with hypertension.
This conference will address these and other issues confronting the clinician who treats challenging patients with diabetes, hypertension, and dyslipidemia. The participant will learn the most current information on these issues and will be able to apply these important clinical principles back to their everyday practise to improve the care of their patients.
By the end of this educational activity, an attendee will be able to,
• Express an efficient and effective assessment and monitoring plan of a patient's condition as it relates to hypertension, diabetes, and dyslipidemia.
• Employ current guidelines in the diagnosis and management of diabetes, hypertension, and dyslipidemia.
• Form individualized interventions and treatment strategies for patients presenting with hypertension, diabetes, and/or dyslipidemia that will lead to the reduction of modifiable risk factors and improved long term outcomes.
Additional details will be posted as soon as they are available.
|Registration Type||End Date||Price|
|Physicians Registration Fee||25 Jun,2020||USD 655.00|
|Residents and other healthcare professionals Registration Fee||25 Jun,2020||USD 610.00|
|LIVE streaming webcast Registration Fee||25 Jun,2020||USD 525.00|
Plan Your Travel
Reviews Given by People
Hotels Near Venue
Subscribe to our Newsletterx
Subscribe to our newsletter and receive updates on medical conferences, board review courses and news